Julia Puppin Chaves Fulber (Julia P C Fulber)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Tandem Mass Spectrometry

High Performance Liquid Chromatography

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Zeyu Yang, Barbara Cristina Martins Fernandes Paes, Julia Puppin Chaves Fulber, Michelle Yen Tran, Omar Farnós, Amine A Kamen
Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine. Vaccines 11 (4) (2023)
Maryam Youssef, Cynthia Hitti, Julia Puppin Chaves Fulber, Amine A Kamen
Enabling mRNA Therapeutics: Current Landscape and Challenges in Manufacturing. Biomolecules 13 (10) (2023)
Zeyu Yang, Barbara Cristina Martins Fernandes Paes, Julia Puppin Chaves Fulber, Michelle Yen Tran, Omar Farnós, Amine A Kamen
Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine. Vaccines 11 (4) (2023)
Zeyu Yang, Barbara Cristina Martins Fernandes Paes, Julia Puppin Chaves Fulber, Michelle Yen Tran, Omar Farnós, Amine A Kamen
Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine. Vaccines 11 (4) (2023)
Zeyu Yang, Barbara Cristina Martins Fernandes Paes, Julia Puppin Chaves Fulber, Michelle Yen Tran, Omar Farnós, Amine A Kamen
Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine. Vaccines 11 (4) (2023)
Julia Puppin Chaves Fulber, Amine A Kamen
Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use. Viruses 14 (5) (2022)
Julia Puppin Chaves Fulber, Omar Farnós, Sascha Kiesslich, Zeyu Yang, Shantoshini Dash, Leonardo Susta, Sarah K Wootton, Amine A Kamen
Process Development for Newcastle Disease Virus-Vectored Vaccines in Serum-Free Vero Cell Suspension Cultures. Vaccines 9 (11) (2021)